Cargando…

Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion

INTRODUCTION: Haycocknema perplexum is an exceedingly rare cause of parasitic myositis endemic to Australia, more specifically, Tasmania and North Queensland. There is a paucity of literature regarding this diagnosis, with only nine previously described cases. DIAGNOSIS: This report details two case...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Kayla, Krishnan, Anirudh, R Iyengar, Krishnan, Robertson, Thomas, White, Richard, Urkude, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119132/
https://www.ncbi.nlm.nih.gov/pubmed/35663589
http://dx.doi.org/10.1136/bmjno-2022-000290
_version_ 1784710641967169536
author Ward, Kayla
Krishnan, Anirudh
R Iyengar, Krishnan
Robertson, Thomas
White, Richard
Urkude, Ravindra
author_facet Ward, Kayla
Krishnan, Anirudh
R Iyengar, Krishnan
Robertson, Thomas
White, Richard
Urkude, Ravindra
author_sort Ward, Kayla
collection PubMed
description INTRODUCTION: Haycocknema perplexum is an exceedingly rare cause of parasitic myositis endemic to Australia, more specifically, Tasmania and North Queensland. There is a paucity of literature regarding this diagnosis, with only nine previously described cases. DIAGNOSIS: This report details two cases of biopsy-confirmed H. perplexum myositis from Townsville University Hospital and describes the first-ever case of subclinical infection. There is limited known information regarding the H. perplexum life cycle and a definitive host which has hindered the development of a non-invasive diagnostic test. A review of the previously described cases has identified the hallmark features of this enigmatic condition: a triad of serological markers including deranged hepatic function, persistent eosinophilia and an elevated creatine kinase. CONCLUSIONS: This report aimed to raise awareness of H. perplexum myositis and the possibility of subclinical infection, which suggests a protracted disease course. Further research is required to identify a non-invasive diagnostic test, given that early diagnosis and timely initiation of albendazole treatment may drastically limit patient disability.
format Online
Article
Text
id pubmed-9119132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-91191322022-06-04 Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion Ward, Kayla Krishnan, Anirudh R Iyengar, Krishnan Robertson, Thomas White, Richard Urkude, Ravindra BMJ Neurol Open Short Report INTRODUCTION: Haycocknema perplexum is an exceedingly rare cause of parasitic myositis endemic to Australia, more specifically, Tasmania and North Queensland. There is a paucity of literature regarding this diagnosis, with only nine previously described cases. DIAGNOSIS: This report details two cases of biopsy-confirmed H. perplexum myositis from Townsville University Hospital and describes the first-ever case of subclinical infection. There is limited known information regarding the H. perplexum life cycle and a definitive host which has hindered the development of a non-invasive diagnostic test. A review of the previously described cases has identified the hallmark features of this enigmatic condition: a triad of serological markers including deranged hepatic function, persistent eosinophilia and an elevated creatine kinase. CONCLUSIONS: This report aimed to raise awareness of H. perplexum myositis and the possibility of subclinical infection, which suggests a protracted disease course. Further research is required to identify a non-invasive diagnostic test, given that early diagnosis and timely initiation of albendazole treatment may drastically limit patient disability. BMJ Publishing Group 2022-05-18 /pmc/articles/PMC9119132/ /pubmed/35663589 http://dx.doi.org/10.1136/bmjno-2022-000290 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Short Report
Ward, Kayla
Krishnan, Anirudh
R Iyengar, Krishnan
Robertson, Thomas
White, Richard
Urkude, Ravindra
Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
title Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
title_full Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
title_fullStr Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
title_full_unstemmed Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
title_short Haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
title_sort haycocknema perplexum myositis: the first description of subclinical disease and a proposed distinctive triad to evoke clinical suspicion
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119132/
https://www.ncbi.nlm.nih.gov/pubmed/35663589
http://dx.doi.org/10.1136/bmjno-2022-000290
work_keys_str_mv AT wardkayla haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion
AT krishnananirudh haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion
AT riyengarkrishnan haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion
AT robertsonthomas haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion
AT whiterichard haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion
AT urkuderavindra haycocknemaperplexummyositisthefirstdescriptionofsubclinicaldiseaseandaproposeddistinctivetriadtoevokeclinicalsuspicion